Actively Recruiting

Phase Not Applicable
Age: 20Years +
All Genders
NCT05737355

Effect of ANKASCIN 568-P Products Regulating Blood Lipid

Led by SunWay Biotech Co., LTD. · Updated on 2025-08-28

80

Participants Needed

1

Research Sites

134 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)

CONDITIONS

Official Title

Effect of ANKASCIN 568-P Products Regulating Blood Lipid

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female over age 20 (women of childbearing age must not be pregnant or breastfeeding during the study)
  • Able to communicate and mentally healthy
  • Body mass index (BMI) between 18 and 35
  • Diagnosed with simple dyslipidemia and not currently needing or choosing not to take lipid-lowering drugs
  • LDL cholesterol between 130 and 190 mg/dL
  • HDL cholesterol below 50 mg/dL
  • No serious diseases such as cancer, heart failure, diabetes, myocardial infarction, liver cirrhosis, moderate to severe liver or kidney dysfunction, stroke
  • Maintain regular daily routine and eating habits during the study
Not Eligible

You will not qualify if you...

  • Triglycerides (TG) 500 mg/dL or higher
  • Blood pressure systolic 200 mmHg or higher, or diastolic 140 mmHg or higher
  • Moderate or severe abnormal liver or kidney function (SGPT or SGOT more than 3 times normal, diagnosed liver cirrhosis, or eGFR 30 ml/min/1.73m2 or lower)
  • Pregnant or breastfeeding women
  • Currently taking traditional Chinese medicine mainly based on red yeast rice
  • Surgery within the past month
  • Serious heart, liver, kidney, or blood diseases; mental illness; inability to comply with study procedures or incomplete data

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tri-Service General Hospital, National Defense Medical Center, Taipei city,

Taipei, Taiwan, 114202

Actively Recruiting

Loading map...

Research Team

S

Sean Lin

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here